Carotid MRI: A tool for monitoring individual response to cardiovascular therapy?

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 1, 2011, Pages 63-80

  Underhill, Hunter R ^a   Yuan, Chun ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; carotid artery; magnetic resonance imaging; monitoring therapy; stroke

Indexed keywords

ATORVASTATIN; CHOLESTEROL; COLESEVELAM; GADOLINIUM; HYPOCHOLESTEROLEMIC AGENT; NICOTINIC ACID; ROSIGLITAZONE; ROSUVASTATIN; SIMVASTATIN;

ARTERIAL WALL THICKNESS; BLEEDING; CALCIFICATION; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT CARE; REVIEW; SENSITIVITY AND SPECIFICITY; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE ANGIOGRAPHY; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; TECHNOLOGY TRANSFER;

EID: 78650384770     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.172     Document Type: Review

References (139)

1. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profle: adjustment for antihypertensive medication. The Framingham Study. Stroke 25(1), 40-43 (1994).
2. Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 31(7), 1588-1601 (2000).
3. Bonita R, Stewart A, Beaglehole R. International trends in stroke mortality: 1970-1985. Stroke 21(7), 989-992 (1990).
4. Thom TJ. Stroke mortality trends. An international perspective. Ann. Epidemiol. 3(5), 509-518 (1993).
5. Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 8(5), 453-463 (2009).
6. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 371(9624), 1612-1623 (2008).
7. Kurl S, Sivenius J, Makikallio TH, Rauramaa R, Laukkanen JA. Exercise workload, cardiovascular risk factor evaluation and the risk of stroke in middle-aged men. J. Intern. Med. 265(2), 229-237 (2009).
8. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340(1), 14-22 (1999).
9. Prati P, Tosetto A, Vanuzzo D et al. Carotid intima media thickness and plaques can predict the occurrence of ischemic cerebrovascular events. Stroke 39(9), 2470-2476 (2008).
10. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362(9395), 1527-1535 (2003).
11. O'Regan C, Wu P, Arora P, Perri D, Mills EJ. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am. J. Med. 121(1), 24-33 (2008).
12. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375(9718), 906-915 (2010).
13. Autret A, Pourcelot L, Saudeau D, Marchal C, Bertrand P, de Boisvilliers S. Stroke risk in patients with carotid stenosis. Lancet 1(8538), 888-890 (1987).
14. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74(6), 1399-1406 (1986).
15. Landry A, Spence JD, Fenster A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 35(4), 864-869 (2004).
16. Saba L, Sanflippo R, Montisci R, Mallarini G. Carotid artery wall thickness: comparison between sonography and multi-detector row CT angiography Neuroradiology 52(2), 75-82 (2010).
17. Toussaint JF, Southern JF, Fuster V, Kantor HL. T2-weighted contrast for NMR characterization of human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15(10), 1533-1542 (1995).
18. U-King-Im JM, Young V, Gillard JH. Carotid-artery imaging in the diagnosis and management of patients at risk of stroke. Lancet Neurol. 8(6), 569-580 (2009).
19. Villines TC, Taylor AJ. Non-invasive atherosclerosis imaging: use to assess response to novel or combination lipid therapies. Curr. Drug Targ. 5(6), 557-564 (2005).
20. Moore WS, Barnett HJ, Beebe HG et al Guidelines for carotid endarterectomy A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 91(2), 566-579 (1995).
21. SVN Task Force for Clinical Practice Guideline Members. 2009 clinical practice guideline for patients undergoing carotid endarterectomy (CEA). J. Vasc. Nurs. 28(1), 21-46 (2010).
22. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic Resonance Imaging: Physical Principles and Sequence Design. John Wiley & Sons, Inc, NY, USA (1999).
23. Dumoulin CL, Hart HR Jr. Magnetic resonance angiography. Radiology 161(3), 717-720 (1986).
24. Hausmann R, Lewin JS, Laub G. Phase-contrast MR angiography with reduced acquisition time: new concepts in sequence design. J. Magn. Reson. Imaging 1(4), 415-422 (1991).
25. Lin W, Abendschein DR, Haacke EM. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J. Magn. Reson. Imaging 7(1), 183-190 (1997). (Pubitemid 28365658)
26. Edelman RR, Mattle HP, Wallner B et al. Extracranial carotid arteries: evaluation with 'black blood' MR angiography. Radiology, 177(1), 45-50 (1990).
27. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. 'Black blood' T2-weighted inversion-recovery MR imaging of the heart. Radiology 199(1), 49-57 (1996).
28. Yarnykh VL, Yuan C. Multislice double inversion-recovery black-blood imaging with simultaneous slice reinversion. J. Magn. Reson. Imaging 17(4), 478-483 (2003).
29. Koktzoglou I, Chung YC, Carroll TJ, Simonetti OP, Morasch MD, Li D. Three-dimensional black-blood MR imaging of carotid arteries with segmented steady-state free precession: initial experience. Radiology 243(1), 220-228 (2007).
30. Wang J, Yarnykh VL, Hatsukami T, Chu B, Balu N, Yuan C. Improved suppression of plaque-mimicking artifacts in black-blood carotid atherosclerosis imaging using a multislice motion-sensitized driven-equilibrium (MSDE) turbo spin-echo (TSE) sequence. Magn. Reson. Med. 58(5), 973-981 (2007).
31. Yarnykh VL, Yuan C. T1-insensitive fow suppression using quadruple inversion-recovery. Magn. Reson. Med. 48(5), 899-905 (2002).
32. Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 107(24), 3047-3052 (2003).
33. Zhu DC, Ferguson MS, DeMarco JK. An optimized 3D inversion recovery prepared fast spoiled gradient recalled sequence for carotid plaque hemorrhage imaging at 3.0 T. Magn. Reson. Imaging 26(10), 1360-1366 (2008).
34. Trivedi RA, JM UK-I, Graves MJ et al. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 35(7), 1631-1635 (2004).
35. Trivedi RA, Mallawarachi C, U-King-Im J et al. Identifying infamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26(7), 1601-1606 (2006).
36. Kooi ME, Cappendijk VC, Cleutjens KB et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107(19), 2453-2458 (2003).
37. Kerwin WS, O'Brien KD, Ferguson MS, Polissar N, Hatsukami TS, Yuan C. Infammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241(2), 459-468 (2006). (Pubitemid 44632892)
38. 18F-FDG PET. Arterioscler. Thromb. Vasc. Biol. 28(7), 1311-1317 (2008).
39. Yuan C, Kerwin WS, Yarnykh VL et al. MRI of atherosclerosis in clinical trials. NMR Biomed. 19(6), 636-654 (2006).
40. Saam T, Hatsukami TS, Takaya N et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology 244(1), 64-77 (2007). (Pubitemid 46981959)
41. Dong L, Kerwin WS, Ferguson MS et al. Cardiovascular magnetic resonance in carotid atherosclerotic disease. J. Cardiovasc. Magn. Reson. 11, 53 (2009).
42. DeMarco JK, Huston J, Nash AK. Extracranial carotid MR imaging at 3T. Magn. Reson. Imaging Clin. N. Am. 14(1), 109-121 (2006).
43. Watanabe Y, Nagayama M. MR plaque imaging of the carotid artery. Neuroradiology 52(4), 253-274 (2010).
44. Kerwin WS, Canton G. Advanced techniques for MRI of atherosclerotic plaque. Top. Magn. Reson. Imaging 20(4), 217-225 (2009).
45. Balu N, Wang J, Dong L, Baluyot F, Chen H, Yuan C. Current techniques for MR imaging of atherosclerosis. Top. Magn. Reson. Imaging 20(4), 203-215 (2009).
46. Leiner T, Gerretsen S, Botnar R et al. Magnetic resonance imaging of atherosclerosis. Eur. Radiol. 15(6), 1087-1099 (2005).
47. Tang TY, Muller KH, Graves MJ et al. Iron oxide particles for atheroma imaging. Arterioscler. Thromb. Vasc. Biol. 29(7), 1001-1008 (2009).
48. Wang J, Balu N, Canton G, Yuan C. Imaging biomarkers of cardiovascular disease. J. Magn. Reson. Imaging 32(3), 502-515 (2010).
49. Underhill HR, Yarnykh VL, Hatsukami TS et al. Carotid plaque morphology and composition: initial comparison between 1.5- and 3.0-T magnetic feld strengths. Radiology 248(2), 550-560 (2008).
50. Hayes CE, Mathis CM, Yuan C. Surface coil phased arrays for high-resolution imaging of the carotid arteries. J. Magn. Reson. Imaging, 6(1), 109-112 (1996).
51. Balu N, Yarnykh VL, Scholnick J, Chu B, Yuan C, Hayes C. Improvements in carotid plaque imaging using a new eight-element phased array coil at 3T. J. Magn. Reson. Imaging 30(5), 1209-1214 (2009).
52. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fbrous, calcifed, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 94(5), 932-938 (1996).
53. Yuan C, Mitsumori LM, Ferguson MS et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 104(17), 2051-2056 (2001).
54. Saam T, Ferguson MS, Yarnykh VL et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler. Thromb. Vasc. Biol. 25(1), 234-239 (2005).
55. Cai J, Hatsukami TS, Ferguson MS et al. In vivo quantitative measurement of intact fbrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 112(22), 3437-3444 (2005).
56. Trivedi RA, U-King-Im J, Graves MJ et al. Multi-sequence in vivo MRI can quantify fbrous cap and lipid core components in human carotid atherosclerotic plaques. Eur. J. Vasc. Endovasc. Surg. 28(2), 207-213 (2004).
57. Puppini G, Furlan F, Cirota N et al. Characterisation of carotid atherosclerotic plaque: comparison between magnetic resonance imaging and histology. Radiol. Med. 111(7), 921-930 (2006).
58. Liu F, Xu D, Ferguson MS et al. Automated in vivo segmentation of carotid plaque MRI with morphology-enhanced probability maps. Magn. Reson. Med. 55(3), 659-668 (2006).
59. Cappendijk VC, Kessels AG, Heeneman S et al. Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaque: initial results. J. Magn. Reson. Imaging 27(6), 1356-1361 (2008).
60. Chu B, Kampschulte A, Ferguson MS et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke 35(5), 1079-1084 (2004).
61. Kampschulte A, Ferguson MS, Kerwin WS et al. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation 110(20), 3239-3244 (2004).
62. Bitar R, Moody AR, Leung G et al. In vivo 3D high-spatial-resolution MR imaging of intraplaque hemorrhage. Radiology 249(1), 259-267 (2008).
63. Ota H, Yarnykh VL, Ferguson MS et al. Carotid intraplaque hemorrhage imaging at 3.0-T MR imaging: comparison of the diagnostic performance of three T1-weighted sequences. Radiology 254(2), 551-563 (2010).
64. Wang J, Ferguson MS, Balu N, Yuan C, Hatsukami TS, Bornert P. Improved carotid intraplaque hemorrhage imaging using a slab-selective phase-sensitive inversion-recovery (SPI) sequence. Magn. Reson. Med. 64(5), 1332-1340 (2010).
65. Hatsukami TS, Ross R, Polissar NL, Yuan C. Visualization of fbrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 102(9), 959-964 (2000).
66. Mitsumori LM, Hatsukami TS, Ferguson MS, Kerwin WS, Cai J, Yuan C. In vivo accuracy of multisequence MR imaging for identifying unstable fbrous caps in advanced human carotid plaques. J. Magn. Reson. Imaging 17(4), 410-420 (2003).
67. Yu W, Underhill HR, Ferguson MS et al. The added value of longitudinal black-blood cardiovascular magnetic resonance angiography in the cross sectional identifcation of carotid atherosclerotic ulceration. J. Cardiovasc. Magn. Reson. 11(1), 31 (2009).
68. Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107(6), 851-856 (2003).
69. Chu B, Ferguson MS, Chen H et al. Magnetic resonance imaging features of the disruption-prone and the disrupted carotid plaque. JACC Cardiovasc. Imaging 2(7), 883-896 (2009).
70. Yuan C, Kerwin WS, Ferguson MS et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J. Magn. Reson. Imaging 15(1), 62-67 (2002).
71. Kwee RM, van Engelshoven JM, Mess WH et al. Reproducibility of fbrous cap status assessment of carotid artery plaques by contrast-enhanced MRI. Stroke 40(9), 3017-3021 (2009).
72. Yuan C, Zhang SX, Polissar NL et al. Identifcation of fbrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 105(2), 181-185 (2002).
73. Murphy RE, Moody AR, Morgan PS et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 107(24), 3053-3058 (2003).
74. Saam T, Cai J, Ma L et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology 240(2), 464-472 (2006).
75. Demarco JK, Ota H, Underhill HR et al. MR carotid plaque imaging and contrast-enhanced MR angiography identifes lesions associated with recent ipsilateral thromboembolic symptoms: an in vivo study at 3T. AJNR Am. J. Neuroradiol. 31(8), 1395-1402 (2010).
76. Kwee RM, van Oostenbrugge RJ, Prins MH et al. Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use. Stroke 41(7), 1389-1393 (2010).
77. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI - initial results. Stroke 37(3), 818-823 (2006).
78. Altaf N, Daniels L, Morgan PS et al. Detection of intraplaque hemorrhage by magnetic resonance imaging in symptomatic patients with mild to moderate carotid stenosis predicts recurrent neurological events. J. Vasc. Surg. 47(2), 337-342 (2008).
79. Singh N, Moody AR, Gladstone DJ et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 252(2), 502-508 (2009).
80. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet 337(8752), 1235-1243 (1991).
81. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet 347(9015), 1591-1593 (1996).
82. Barnett HJ, Taylor DW, Eliasziw M et al. Beneft of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N. Engl. J. Med. 339(20), 1415-1425 (1998).
83. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study JAMA 273(18), 1421-1428 (1995).
84. Halliday A, Mansfeld A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 363(9420), 1491-1502 (2004).
85. Willinek WA. Looking beyond the lumen to predict cerebrovascular events: 'the road less travelled by'. Stroke 37(3), 759-760 (2006).
86. Saam T, Underhill HR, Chu B et al. Prevalence of American Heart Association type VI carotid atherosclerotic lesions identifed by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J. Am. Coll. Cardiol. 51(10), 1014-1021 (2008).
87. Dong L, Underhill HR, Yu W et al. Geometric and compositional appearance of atheroma in an angiographically normal carotid artery in patients with atherosclerosis. AJNR Am. J. Neuroradiol. 31(2), 311-316 (2010).
88. Virmani R, Burke A P, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J. Am. Coll Cardiol. 47(Suppl. 8), C13-C18 (2006).
89. Corti R, Fayad ZA, Fuster V et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 104(3), 249-252 (2001).
90. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106(23), 2884-2887 (2002).
91. Corti R, Fuster V, Fayad ZA et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46(1), 106-112 (2005).
92. Underhill HR, Yuan C, Zhao XQ et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am. Heart J. 155(3), 584 e581-e588 (2008).
93. Lee JM, Wiesmann F, Shirodaria C et al. Early changes in arterial structure and function following statin initiation: quantifcation by magnetic resonance imaging. Atherosclerosis 197(2), 951-958 (2008).
94. Tang TY, Howarth SP, Miller SR et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 53(22), 2039-2050 (2009).
95. Lee JM, Robson MD, Yu LM et al. Effects of high-dose modifed-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J. Am. Coll Cardiol. 54(19), 1787-1794 (2009).
96. Varghese A, Yee MS, Chan CF et al Effect of rosiglitazone on progression of atherosclerosis: insights using 3D carotid cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 11, 24 (2009).
97. Zhao XQ, Phan BA, Chu B et al. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. Am. Heart J. 154(2), 239-246 (2007).
98. Miyauchi K, Takaya N, Hirose T et al Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging. Circ. J. 73(1), 111-115 (2009).
99. Duivenvoorden R, de Groot E, Stroes ES, Kastelein JJ. Surrogate markers in clinical trials - challenges and opportunities. Atherosclerosis 206(1), 8-16 (2009).
100. Makris GC, Lavida A, Nicolaides AN, Geroulakos G. The effect of statins on carotid plaque morphology: a LDL-associated action or one more pleiotropic effect of statins? Atherosclerosis 213(1), 8-20 (2010).
101. Kang S, Wu Y, Li X. Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis. Atherosclerosis 177(2), 433-442 (2004).
102. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35(12), 2902-2909 (2004).
103. Dong L, Kerwin W, Chun H et al. Effect of intensive lipid therapy on atherosclerotic plaque infammation: evaluation of using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in carotid disease. Circulation 120(18 Suppl. II), 1047-1048 (2009).
104. Zhao XQ, Dong L, Hatsukami TS et al. Magnetic resonance imaging of the plaque lipid depletion during lipid therapy: a prospective assessment of effcacy and time-course. Presented at: ACC 2009. Orlando, FL, USA, 28-31 March 2009.
105. Adams GJ, Greene J, Vick GW 3rd et al. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magn. Reson. Imaging 22(9), 1249-1258 (2004).
106. Takaya N, Yuan C, Chu B et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 111(21), 2768-2775 (2005).
107. Saam T, Yuan C, Chu B et al. Predictors of carotid atherosclerotic plaque progression as measured by noninvasive magnetic resonance imaging. Atherosclerosis 194(2), e34-e42 (2007). (Pubitemid 47513067)
108. Boussel L, Arora S, Rapp J et al. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging - multicenter trial. Radiology 252(3), 789-796 (2009).
109. Underhill HR, Yuan C, Yarnykh VL et al. Arterial remodeling in subclinical carotid artery disease. JACC Cardiovasc. Imaging 2(12), 1381-1389 (2009).
110. Underhill HR, Yuan C, Yarnykh VL et al. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. AJNR Am. J. Neuroradiol. 31(3), 487-493 (2010).
111. Hayashi K, Mani V, Nemade A et al. Variations in atherosclerosis and remodeling patterns in aorta and carotids. J. Cardiovasc. Magn. Reson. 12, 10 (2010).
112. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. 316(22), 1371-1375 (1987). (Pubitemid 17079680)
113. Ota H, Yu W, Underhill HR et al. Hemorrhage and large lipid-rich necrotic cores are independently associated with thin or ruptured fbrous caps: an in vivo 3T MRI study. Arterioscler. Thromb. Vasc. Biol. 29(10), 1696-1701 (2009).
114. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the unstable plaque. Prog. Cardiovasc. Dis. 44(5), 349-356 (2002).
115. Saam T, Hatsukami TS, Yarnykh VL et al. Reader and platform reproducibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J. Magn. Reson. Imaging 26(2), 344-352 (2007).
116. Takaya N, Cai J, Ferguson MS et al. Intra- and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J. Magn. Reson. Imaging 24(1), 203-210 (2006).
117. Touze E, Toussaint JF, Coste J et al. Reproducibility of high-resolution MRI for the identifcation and the quantifcation of carotid atherosclerotic plaque components: consequences for prognosis studies and therapeutic trials. Stroke 38(6), 1812-1819 (2007).
118. Syed MA, Oshinski JN, Kitchen C, Ali A, Charnigo RJ, Quyyumi AA. Variability of carotid artery measurements on 3-Tesla MRI and its impact on sample size calculation for clinical research. Int. J. Cardiovasc. Imaging 25(6), 581-589 (2009).
119. Saam T, Kerwin WS, Chu B et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J. Cardiovasc. Magn. Reson. 7(5), 799-808 (2005).
120. Kang X, Polissar NL, Han C, Lin E, Yuan C. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn. Reson. Med. 44(6), 968-972 (2000).
121. Li F, Yarnykh VL, Hatsukami TS et al. Scan-rescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3T. J. Magn. Reson. Imaging 31(1), 168-176 (2010).
122. Nissen SE, Tuzcu EM, Schoenhagen P et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291(9), 1071-1080 (2004). (Pubitemid 38541684)
123. Bots ML, Evans GW, Riley WA, Grobbee DE. Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view. Stroke 34(12), 2985-2994 (2003).
124. Gould AL, Koglin J, Bain RP et al. Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness. Clin. Trials 6(4), 305-319 (2009).
125. Grobner T. Gadolinium - a specifc trigger for the development of nephrogenic fbrosing dermopathy and nephrogenic systemic fbrosis Nephrol. Dial. Transplant. 21(4), 1104-1108 (2006).
126. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fbrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest. Radiol. 43(2), 141-144 (2008).
127. Wang J, Yarnykh VL, Yuan C. Enhanced image quality in black-blood MRI using the improved motion-sensitized driven-equilibrium (iMSDE) sequence. J. Magn. Reson. Imaging 31(5), 1256-1263 (2010).
128. Balu N, Yarnykh VL, Chu B, Wang J, Hatsukami T, Yuan C. Carotid plaque assessment using fast 3D isotropic resolution black-blood MRI. Magn. Reson. Med. DOI: 10.1002/mrm.22642 (2010) (Epub ahead of print).
129. Balu N, Kerwin WS, Chu B, Liu F, Yuan C. Serial MRI of carotid plaque burden: infuence of subject repositioning on measurement precision. Magn. Reson. Med. 57(3), 592-599 (2007).
130. Homburg PJ, Rozie S, van Gils MJ et al. Atherosclerotic plaque ulceration in the symptomatic internal carotid artery is associated with nonlacunar ischemic stroke. Stroke 41(6), 1151-1156 (2010).
131. Steinman DA, Thomas JB, Ladak HM, Milner JS, Rutt BK, Spence JD. Reconstruction of carotid bifurcation hemodynamics and wall thickness using computational fuid dynamics and MRI. Magn. Reson. Med. 47(1), 149-159 (2002).
132. Li ZY, Howarth SP, Tang T et al. Structural analysis and magnetic resonance imaging predict plaque vulnerability: a study comparing symptomatic and asymptomatic individuals. J. Vasc. Surg. 45(4), 768-775 (2007).
133. Tang D, Yang C, Zheng J et al. 3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann. Biomed. Eng. 32(7), 947-960 (2004).
134. Teng Z, Canton G, Yuan C et al. 3D critical plaque wall stress is a better predictor of carotid plaque rupture sites than fow shear stress: an in vivo MRI-based 3D FSI study. J. Biomech. Eng. 132(3), 031007 (2010).
135. Howard G, Howard VJ, Katholi C, Oli MK, Huston S. Decline in US stroke mortality: an analysis of temporal patterns by sex, race, and geographic region. Stroke 32(10), 2213-2220 (2001).
136. Wasserman BA, Sharrett AR, Lai S et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke 39(2), 329-335 (2008).
137. Underhill HR, Hatsukami TS, Cai J et al. A noninvasive imaging approach to assess plaque severity: the carotid atherosclerosis score. AJNR Am. J. Neuroradiol. 31(6), 1068-1075 (2010).
138. American Heart Association. Heart Disease & Stroke Statistics - 2009 Update. American Heart Association, TX, USA (2009).
139. Underhill HR, Hatsukami TS, Fayad ZA, Fuster V, Yuan C. MRI of carotid atherosclerosis: clinical implications and future directions. Nat. Rev. Cardiol. 7(3), 165-173 (2010).